Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Attitudes toward colorectal cancer screening tests.

Ling BS, Moskowitz MA, Wachs D, Pearson B, Schroy PC.

J Gen Intern Med. 2001 Dec;16(12):822-30.

2.

Family physicians' choices of and opinions on colorectal cancer screening modalities.

Zettler M, Mollon B, da Silva V, Howe B, Speechley M, Vinden C.

Can Fam Physician. 2010 Sep;56(9):e338-44.

3.

Patient perceptions of stool-based DNA testing for colorectal cancer screening.

Schroy PC 3rd, Heeren TC.

Am J Prev Med. 2005 Feb;28(2):208-14.

PMID:
15710277
4.

The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening.

Almog R, Ezra G, Lavi I, Rennert G, Hagoel L.

Eur J Cancer Prev. 2008 Oct;17(5):430-7. doi: 10.1097/CEJ.0b013e328305a0fa.

PMID:
18714185
5.

Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening.

DeBourcy AC, Lichtenberger S, Felton S, Butterfield KT, Ahnen DJ, Denberg TD.

J Gen Intern Med. 2008 Feb;23(2):169-74. Epub 2007 Dec 21.

6.

Knowledge and attitudes of primary health care physicians and nurses with regard to population screening for colorectal cancer in Balearic Islands and Barcelona.

Ramos M, Esteva M, Almeda J, Cabeza E, Puente D, Saladich R, Boada A, Llagostera M.

BMC Cancer. 2010 Sep 20;10:500. doi: 10.1186/1471-2407-10-500.

7.
8.

Preferences for colorectal cancer screening among racially/ethnically diverse primary care patients.

Hawley ST, Volk RJ, Krishnamurthy P, Jibaja-Weiss M, Vernon SW, Kneuper S.

Med Care. 2008 Sep;46(9 Suppl 1):S10-6. doi: 10.1097/MLR.0b013e31817d932e.

PMID:
18725820
9.

Colorectal cancer screening: physician attitudes and practices.

Taylor ML, Anderson R.

WMJ. 2002;101(5):39-43.

PMID:
12239980
10.

Patients' anxiety and expectations: how they influence family physicians' decisions to order cancer screening tests.

Haggerty J, Tudiver F, Brown JB, Herbert C, Ciampi A, Guibert R.

Can Fam Physician. 2005 Dec;51:1658-9.

11.

Patient preferences for colorectal cancer screening: how does stool DNA testing fare?

Schroy PC 3rd, Lal S, Glick JT, Robinson PA, Zamor P, Heeren TC.

Am J Manag Care. 2007 Jul;13(7):393-400.

12.

Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance.

Sharma VK, Corder FA, Raufman JP, Sharma P, Fennerty MB, Howden CW.

Am J Gastroenterol. 2000 Aug;95(8):2068-73.

PMID:
10950059
13.

Validation of self-reported history of colorectal cancer screening.

Khoja S, McGregor SE, Hilsden RJ.

Can Fam Physician. 2007 Jul;53(7):1192-7.

14.

Screening preferences of patients at familial risk of colorectal cancer.

Schroy Iii PC, Glick JT, Robinson PA, Heeren T.

Dig Dis Sci. 2007 Oct;52(10):2788-95. Epub 2007 Apr 3.

PMID:
17404844
15.

Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test.

Turner B, Myers RE, Hyslop T, Hauck WW, Weinberg D, Brigham T, Grana J, Rothermel T, Schlackman N.

J Gen Intern Med. 2003 May;18(5):357-63.

16.

Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.

Worthley DL, Smith A, Bampton PA, Cole SR, Young GP.

Eur J Gastroenterol Hepatol. 2006 Oct;18(10):1079-83.

PMID:
16957514
17.

Patient preferences for colorectal cancer screening.

Leard LE, Savides TJ, Ganiats TG.

J Fam Pract. 1997 Sep;45(3):211-8.

PMID:
9300000
18.

Physicians' use of nonphysician healthcare providers for colorectal cancer screening.

Sansbury LB, Klabunde CN, Mysliwiec P, Brown ML.

Am J Prev Med. 2003 Oct;25(3):179-86.

PMID:
14507523
19.
20.

Utilization of colorectal cancer screening tests: a 1997 survey of Massachusetts internists.

Schroy PC 3rd, Geller AC, Crosier Wood M, Page M, Sutherland L, Holm LJ, Heeren T.

Prev Med. 2001 Nov;33(5):381-91.

PMID:
11676578

Supplemental Content

Support Center